Evidence map›Paper›PMID 35928447›Full record

ArticleFrontiers in genetics2022

A novel mutation in the

Peiqiang Li, Xiande Huang, Senmao Chai, Dalin Zhu, Huirong Huang, Fengdie Ma, Shasha Zhang, Xiaodong Xie

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Peiqiang LiInstitute of Genetics, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Xiande HuangDepartment of Urology, Gansu Provincial Hospital, Lanzhou, China.
Senmao ChaiInstitute of Genetics, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Dalin ZhuMedical Imaging Center, Gansu Province Maternal and Child-care Hospital, Lanzhou, China.
Huirong HuangDepartment of Respiratory Medicine, Lanzhou University Second Hospital, Lanzhou, China.
Fengdie MaInstitute of Genetics, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Shasha ZhangInstitute of Genetics, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Xiaodong XieInstitute of Genetics, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Lanzhou University · CNGansu Provincial Hospital · CNGansu Provincial Maternal and Child Health Hospital · CNLanzhou University Second Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary Spastic Paraplegia (HSP) is considered to be one of the common neurodegenerative diseases with marked genetic heterogeneity. Recently, the mutations in ubiquitin-associated protein 1 (

Indexed as

case reporthereditary spastic paraplegianovel mutationUBAP1whole-exome sequencing

Identifiers

PMID35928447
PMCPMC9344137
OpenAlexW4285804723

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.